Cardiac Biotech Solutions Inc.
CBSC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.46M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.46 Million |
|---|---|
| Enterprise Value | $6.12 Million |
| Earnings per Share | $-0.01 |
| Beta | 1.93 |
| Outstanding Shares | 166,437,591 |
Return
| Return on Equity | 38.47% |
|---|---|
| Return on Assets | -169.08% |
| Return on Invested Capital | 70.15% |
Valuation & Multiples
| P/E Ratio | -7.5 |
|---|---|
| PEG | 26.71 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 41.37 |
| Enterprise Value to EBIT | -5.23 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | -0.3 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cardiac Biotech Solutions Inc.
4 employees
CEO: Charles K. Martin
Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devic...